TOI shareholders approve reverse stock split up to 1:40; re-elect all 8 directors

Oncology Institute, Inc.

Reverse stock split approved at ratio between 1:5 and 1:40, board discretion within one year.
All eight director nominees elected; Richard Barasch received 39.2M votes for, 654k withheld.
Ratification of BDO USA as auditor for FY2025 approved with 61.2M for, 682k against.
Turnout of 61.9M shares representing 81.7% of outstanding common stock.

item 5.07

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001079973-25-000774
form_type: 8-K
ticker: TOI
cik: 0001799191
company_name: Oncology Institute, Inc.
filed_at: 2025-05-08T23:59:59+00:00
discovered_at: 2026-05-14T18:02:49.760147+00:00
generated_at: 2026-05-22T05:11:23.034134+00:00
sec_items: ["5.07"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001079973-25-000774
json_url: https://secwatch.observer/filing/0001079973-25-000774.json
markdown_url: https://secwatch.observer/filing/0001079973-25-000774.md
text_url: https://secwatch.observer/filing/0001079973-25-000774.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/0001079973-25-000774-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/toi_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001079973-25-000774

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.